Abstract:Patent foramen ovale (PFO) represents the most common congenital heart disease (CHD) among subjects from general population having a prevalence ranging between 20 and 30% [ [1] Rigatelli G. Pedon L. Zecchel R. Dell’Avvocata F. Carrozza A. Zennaro M. Mazza A. Zuin M. Russo M. Zanchetta M. Long-term outcomes and complications of Intracardiac echocardiography-assisted patent foramen ovale closure in 1,000 consecutive patients. J. Interv. Cardiol. 2016; 29: 530-538https://doi.org/10.1111/joic.12325 Crossref PubMed Scopus (31) Google Scholar ]. Over the years, several investigations have demonstrated that PFO is implicated in the pathogenesis of different medical conditions [ 2 Rigatelli G. Dell’Avvocata F. Cardaioli P. Giordan M. Braggion G. Aggio S. Chinaglia M. Mandapaka S. Kuruvilla J. Chen J.P. Nanjundappa A. Permanent right-to-left shunt is the key factor in managing patent foramen ovale. J. Am. Coll. Cardiol. 2011; 58: 2257-2261https://doi.org/10.1016/j.jacc.2011.06.06422078434 Crossref PubMed Scopus (55) Google Scholar , 3 Zuin M. Rigatelli G. Rigatelli A. Ronco F. Conte L. Roncon L. Mazza A. Correlations between serum homocysteine levels and RoPE score in patients with patent foramen ovale. Heart Vessel. 2020; 35: 705-711https://doi.org/10.1007/s00380-019-01528-5 Crossref PubMed Scopus (3) Google Scholar , 4 Rigatelli G. Dell’Avvocata F. Ronco F. Cardaioli P. Giordan M. Braggion G. Aggio S. Chinaglia M. Rigatelli G. Chen J.P. Primary transcatheter patent foramen ovale closure is effective in improving migraine in patients with high-risk anatomic and functional characteristics for paradoxical embolism. JACC Cardiovasc. Interv. 2010; 3: 282-287https://doi.org/10.1016/j.jcin.2009.11.019 Crossref PubMed Scopus (36) Google Scholar ] though two main mechanisms: the former represented by the “traditional” paradoxical embolism and the latter due to the Right-to-Left shunt (RLS)-induced left atrial cardiomyopathy [ [5] Rigatelli G. Aggio S. Cardaioli P. Braggion G. Giordan M. Dell’avvocata F. Chinaglia M. Rigatelli G. Roncon L. Chen J.P. Left atrial dysfunction in patients with patent foramen ovale and atrial septal aneurysm: an alternative concurrent mechanism for arterial embolism?. JACC Cardiovasc. Interv. 2008; 2: 655-662https://doi.org/10.1016/j.jcin.2009.05.010 Crossref Scopus (89) Google Scholar , [6] Rigatelli G. Zuin M. Adami A. Aggio S. Lanza D. d’Elia K. Braggion G. Russo M. Mazza A. Roncon L. Left atrial enlargement as a maker of significant high-risk patent foramen ovale. Int. J. Card. Imaging. 2019; 35: 2049-2056https://doi.org/10.1007/s10554-019-01666-x Crossref Scopus (10) Google Scholar ]. Notably, during the latest two decades, due to the widespread diffusion of echocardiography, the identification of either asymptomatic or thrombus straddling a PFO (TSPFO) has drastically increased, especially in patients with some life-threatening disease such as acute pulmonary embolism (PE) or ischemic stroke (IS) [ 7 Zhang M. Tan S. Patel V. Zalta B.A. Shmukler A. Levsky J.M. Jain V.R. Shaban N.M. Haramati L.B. Patent foramen ovale in patients with pulmonary embolism: a prognostic factor on CT pulmonary angiography?. J. Cardiovasc. Comput.Tomogr. 2017; 12: 271-274https://doi.org/10.1016/j.jcct.2017.11.009 Abstract Full Text Full Text PDF PubMed Scopus (5) Google Scholar , 8 Rigatelli G. Zuin M. Not all patent foramen ovales are alike!. Thromb. Res. 2021; 203: 81https://doi.org/10.1016/j.thromres.2021.04.022 Abstract Full Text Full Text PDF PubMed Scopus (1) Google Scholar , 9 Consoli D. Paciaroni M. Aguggia M. Melis M. Malferrari G. Vidale S. Cerrato P. Sacco S. Gandolfo C. Bovi P. Serrati C. Del Sette M. Cavallini A. Diomedi M. Postorino P. Ricci S. Prevalence of patentforamen ovale in ischemic stroke in Italy: the SISIFO study. Neurol. Sci. 2014; 35: 867-873https://doi.org/10.1007/s10072-013-1615-2 Crossref PubMed Scopus (6) Google Scholar ]. As a matter of a fact, in current daily clinical practice, TSPFO is generally recognized as a source of acute IS. In this number of the journal, Shah and colleagues performed an interesting analysis based on patient-level data, investigating whether acute myocardial infarction (AMI) or IS in patients having TSPFO upon the admission, may be associated with a higher in-hospital mortality [ [10] Shah P. Jimenez-Ruiz A. Gibson A. Vargas-González J.C. Bres-Bullrich M. Bagur R. Sposato L.A. Association between acute myocardial infarction and death in 386 patients with a thrombus straddling a patent foramen ovale. Int. J. Cardiol. 2021; S0167-5273 (Epub ahead of print): 01101-01103https://doi.org/10.1016/j.ijcard.2021.07.007 Abstract Full Text Full Text PDF Scopus (1) Google Scholar ]. For this purpose, the authors performed a systematic search, without language restrictions, describing case-reports or series of adult patients with TSPFO between 1950 to October 30, 2020.

Abstract TP225: Prevalence of Patent Foramen Ovale in Patients With Cancer-Related Stroke

Prevalence of right-to-left shunt in stroke patients with cancer

Patent Foramen Ovale As A Preferential Mechanism For Increasing The Likelihood Of Brain Tumor Metastasis

Thrombus Straddling a Patent Foramen Ovale: Also a Myocardial Infarction Matter?

Association of Preoperatively Diagnosed Patent Foramen Ovale With Perioperative Ischemic Stroke

Embolic implications of combined risk factors in patients with patent foramen ovale (the CARPE criteria): consideration for primary prevention closure?

Atrial septal aneurysm contribution to the risk of cryptogenic stroke in patients with patent foramen ovale: A brief updated systematic review and meta-analysis.

Closing Patent Foramen Ovale in Cryptogenic Stroke: the Underscored Importance of Other Interatrial Shunt Variants

Patent foramen ovale and long-term risk of ischaemic stroke after surgery

Deep vein thrombosis in patients with stroke or transient ischemic attack presenting with patent foramen ovale: a retrospective observational study

Deep Vein Thrombosis and Pulmonary Embolism Among Patients With a Cryptogenic Stroke Linked to Patent Foramen Ovale—A Review of the Literature

Increased Blood Residence Time As Markers of High-Risk Patent Foramen Ovale.

Cancer and left atrial enlargement in patients with ischemic stroke

Assessment of the Characteristics of Patent Foramen Ovale Associated with Cryptogenic Stroke

Persistent Venous Valves Correlate with Increased Shunt and Multiple Preceding Cryptogenic Embolic Events in Patients with Patent Foramen Ovale: an Intracardiac Echocardiographic Study

Prevalence of Patent Foramen Ovale in a Cohort of Children With Cryptogenic Ischemic Stroke

Acute Ischemic Stroke Superimposed on Acute Pulmonary Embolism in the Presence of Patent Foramen Ovale: A Case Report

Abstract TP230: Atrial Fibrillation and Short-Term Outcomes After Cancer-Related Ischemic Stroke

Patent Foramen Ovale-Associated Stroke: A Neurologist's Perspective

Factors associated with patent foramen ovale-related stroke: SAFAS study

The association of different right atrium anatomical-functional characteristics correlates with the risk of paradoxical stroke: an intracardiac echocardiographic study.